ENDRA Life Sciences Granted European Patent EP4021284 Titled "Method And System For Determining At Least One Parameter Of Interest Of A Material For Use In Thermoacoustic Ultrasonic Imaging"
Portfolio Pulse from Benzinga Newsdesk
ENDRA Life Sciences has been granted European Patent EP4021284 for a method and system used in thermoacoustic ultrasonic imaging. This patent could enhance their technological capabilities and market position in the medical imaging sector.
June 12, 2024 | 7:58 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
ENDRA Life Sciences has been granted a European patent for a method and system in thermoacoustic ultrasonic imaging, which could strengthen their technological edge and market position.
The granting of a European patent for a new method and system in thermoacoustic ultrasonic imaging is a significant milestone for ENDRA Life Sciences. This could enhance their technological capabilities and market position, potentially leading to increased investor confidence and a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100